Battipaglia, Giorgia (2019) FECAL MICROBIOTA TRANSPLANTATION BEFORE OR AFTER ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES CARRYING MULTIDRUG-RESISTANCE BACTERIA. [Tesi di dottorato]

[img]
Preview
Text
Battipaglia_Giorgia_31.pdf

Download (1MB) | Preview
[error in script] [error in script]
Item Type: Tesi di dottorato
Lingua: English
Title: FECAL MICROBIOTA TRANSPLANTATION BEFORE OR AFTER ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES CARRYING MULTIDRUG-RESISTANCE BACTERIA
Creators:
CreatorsEmail
Battipaglia, Giorgiagiorgicchia@gmail.com
Date: 7 January 2019
Number of Pages: 61
Institution: Università degli Studi di Napoli Federico II
Department: Medicina Clinica e Chirurgia
Dottorato: Terapie avanzate biomediche e chirirgiche
Ciclo di dottorato: 31
Coordinatore del Corso di dottorato:
nomeemail
Di Minno, Giovannidiminno@unina.it
Tutor:
nomeemail
Pane, FabrizioUNSPECIFIED
Date: 7 January 2019
Number of Pages: 61
Uncontrolled Keywords: fecal microbiota transplantation hematologic malignancies multidrug resistant bacteria
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/07 - Microbiologia e microbiologia clinica
Area 06 - Scienze mediche > MED/09 - Medicina interna
Area 06 - Scienze mediche > MED/12 - Gastroenterologia
Area 06 - Scienze mediche > MED/15 - Malattie del sangue
Area 06 - Scienze mediche > MED/17 - Malattie infettive
Date Deposited: 08 Jan 2019 08:35
Last Modified: 16 Jun 2020 10:03
URI: http://www.fedoa.unina.it/id/eprint/12716

Abstract

Fecal microbiota transplantation is an effective treatment in recurrent Clostridium difficile infection. Promising results to eradicate multidrug-resistant bacteria have also been reported with this procedure, but there are safety concerns in immunocompromised patients. We report results in 10 adult patients colonized with multidrug-resistant bacteria, undergoing fecal microbiota transplantation before (n=4) or after (n=6) allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Stools were obtained from healthy related or unrelated donors. Fecal material was delivered either by enema or via nasogastric tube. Patients were colonized or had infections from either carbapenemase-producing bacteria (n=8) or vancomycin-resistant enterococci (n=2). The median age at fecal microbiota transplantation was 48 (range 16-64) years. Three patients needed a second transplant from the same donor, due to initial failure of the procedure. With a median follow-up of 13 (range 4-40) months, decolonization was achieved in seven out of ten patients. In all patients, fecal microbiota transplantation was safe: one patient presented with constipation during the first 5 days after FMT and 2 patients had grade I diarrhea. One case of gut grade III acute graft-versus-host disease occurred after fecal microbiota transplantation. In patients carrying or infected by multidrug-resistant bacteria, fecal microbiota transplantation is an effective and safe decolonization strategy, even in those with hematologic malignancies undergoing hematopoietic stem cell transplantation.

Actions (login required)

View Item View Item